Intelligence · Clinical Pipeline
Oncology · Phase II
Oncology programs at Phase II — ClinicalTrials.gov pipeline intelligence.
- Programs
- 2,640
Quick answer
Oncology Phase II programs: NovaPharmaNews indexes 2,640 matching clinical development programs from ClinicalTrials.gov with sponsor, modality, and NCT cross-links.
Top sponsors
- First People's Hospital 261 programs
- Chinese Academy of 199 programs
- George Institute for 119 programs
- United Therapeutics Europe 112 programs
- Telethon Foundation 91 programs
- Takeda 79 programs
- Regeneron UK 71 programs
- MSD Merck Sharp 63 programs
- Ningbo Cancer Hospital 62 programs
- Anaxis Pharma 57 programs
- AstraZeneca 52 programs
- HOFFMANN-LA ROCHE 50 programs
-
[203Pb]VMT-α-NET
Perspective Therapeutics
Neuroendocrine Tumors Unresectable
1 trial -
[203Pb]VMT01
Perspective Therapeutics
Recurrent Melanoma (Skin)
1 trial -
[68Ga]BED003 injection
Blue Earth Diagnostics Ireland Ltd
Colorectal cancer (CRC), gastric cancer (GC), pancreatic ductal adenocarcinoma (PDAC), invasive lobular breast cancer (ILC), and epithelial ovarian cancer (EOC).
1 trial -
[90Y]Y-PentixaTher, LysaKare 25 g/25 g solution for infusion, [68Ga]Ga-PentixaFor
Alphapharm Pty Ltd
Central nervous system (CNS) lymphoma; recurrent or refractory primary or isolated secondary
1 trial -
abituzumab
United Therapeutics Europe Ltd
Metastatic Colorectal Cancer
1 trial -
aflibercept + FOLFIRI
Regeneron UK Limited
Metastatic Colorectal Cancer
1 trial -
aglatimagene besadenovec
Candel Therapeutics
Prostate Cancer
1 trial -
aglatimagene besadenovec + valacyclovir
Candel Therapeutics
Prostate Cancer Patients Treated by Radiotherapy
1 trial -
alisertib
Takeda
Malignant Rhabdoid Tumor
1 trial -
alpha 1H, Placebo product for Alpha1H
Lacuna Pharma Pty Ltd
Non-muscle invasive bladder cancer awaiting transurethral surgery
1 trial -
anastrozole
Atrium Therapeutics
Female Breast Carcinoma
1 trial -
anlotinib
Fudan University
Extensive-stage Small Cell Lung Cancer
1 trial -
anlotinib
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Sarcoma, Soft Tissue
1 trial -
anlotinib +TQB2450 + Oxaliplatin+S-1
The First People's Hospital of Lianyungang
Advanced Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma
1 trial -
anlotinib combined with penpulimab
The First People's Hospital of Lianyungang
Non-small Cell Lung Cancer
1 trial -
anlotinib+TQB2450+nab-paclitaxel+cisplatin
The First People's Hospital of Lianyungang
Advanced Biliary Tract Cancer
1 trial -
anti-BCMA CAR-T
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Plasma Cell Leukemia
1 trial -
anti-CD133-CAR vector-transduced T cells
Chinese PLA General Hospital
Liver Cancer
1 trial -
anti-CD7 CAR-pNK cells
The First People's Hospital of Lianyungang
Acute Myeloid Leukemia
1 trial -
anti-FLT3 CAR-T
The First People's Hospital of Lianyungang
Acute Myeloid Leukemia
1 trial -
anti-IL8 mAb, Ipilimumab, anti-IL8 mAb, 5% dextrose solution for injection, OPDIVO 10 mg/mL concentrate for solution for infusion., Ipilimumab, 0.9% sodium chloride solution for injection
Bristol-Myers Squibb Australia Pty Ltd
Advanced solid tumors
1 trial -
anti-MUC1 CAR-pNK cells
The First People's Hospital of Lianyungang
Hepatocellular Carcinoma
1 trial -
artesunate
Hospital Authority, Hong Kong
Colorectal Cancer
1 trial -
asparaginase Erwinia chrysanthemi
Jazz Pharmaceuticals Ireland Limited
Acute Lymphoblastic Leukemia
1 trial -
auranofin
Ultragenyx UK Limited
Chronic Lymphocytic Leukemia (CLL)
1 trial -
autologous dendritic cells pulsed with tumor lysate antigen Vaccine
NORTHWEST BIOTHERAPEUTICS INC
Giant Cell Glioblastoma
1 trial -
avelumab
Nektar Therapeutics UK Limited
Squamous Cell Carcinoma of the Head and Neck (SCCHN)
1 trial -
avelumab
Samsung Bioepis NL B.V.
Lymphoma, Extranodal NK-T-Cell
1 trial -
avelumab (PD-L1 inhibitor immunotherapy) + lurbinectedin
Jazz Pharmaceuticals Ireland Limited
Metastatic Cancer
1 trial -
azenosertib
Zentalis Pharmaceuticals
High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
1 trial -
befotertinib
Xiyuan Hospital of China Academy of Chinese Medical Sciences
NSCLC (Non-small Cell Lung Cancer)
1 trial -
bendamustine
Teva Pharma GmbH
Hodgkin Lymphoma
2 trials -
bendamustine and rituximab
Teva Pharma GmbH
Non-Hodgkin's Lymphoma
1 trial -
bevacizumab
United Therapeutics Europe Ltd
Colorectal Cancer
1 trial -
bevacizumab [Avastin]
Hoffmann-La Roche
Liver Cancer
1 trial -
bexarotene
LIGAND PHARMACEUTICALS INC
Cutaneous T-Cell Lymphoma
1 trial -
bexarotene
LIGAND PHARMACEUTICALS INC
Breast Cancer
1 trial -
biricodar dicitrate
Vertex Pharmaceuticals (Australia) Pty.
Lung Cancer
1 trial -
bleomycin sulfate
Children's Hospital of Fudan University
Childhood Germ Cell Tumor
1 trial -
cRGD-ZW800-1
Disc Medicine
Squamous cell carcinoma of the larynx and hypopharynx
1 trial -
cRGD-ZW800-1
Disc Medicine
Oral cancer
1 trial -
cadonilimab combined +paclitaxel (albumin-bound)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Gastric Adenocarcinoma
1 trial -
cadonilizumab combined with neoadjuvant radiochemotherapy
The First People's Hospital of Lianyungang
Esophageal Squamous Cell Carcinoma
1 trial -
capecitabine
Cardiff Oncology
Pancreatic Cancer
1 trial -
carboplatin
Cardiff Oncology
Bladder Cancer
1 trial -
cardonilizumab combined with renvastinib
The First People's Hospital of Lianyungang
Resectable Clear Cell Carcinoma of the Kidney
1 trial -
cemacabtagene ansegedleucel
Allogene Therapeutics
Large B-cell Lymphoma
1 trial -
cemiplimab
Regeneron UK Limited
Melanoma
1 trial
Frequently asked questions
How many oncology Phase II programs exist?
2,640 programs match both the therapeutic area and stage filters in our published index.
Data attribution: Data sources · All pipeline programs